Clinical trial Recruiting at 1 site Observational Ages 21 to 45 Women only

Investigating bile acids and genetic mutations in pregnancy-related liver disorder in Indian women

Official title: Bile Acids Metabolism and Genetic Mutation Profile in the Etiopathogenesis of Intrahepatic Cholestasis of Pregnancy in Indian Population- A Prospective Study

Run by Post Graduate Institute of Medical Education and Research, Chandigarh · NCT05691036 · Data updated 2026-11-12

This study is testing the connection between bile acids and genetic changes in Indian women with a pregnancy-related liver condition called Intrahepatic Cholestasis of Pregnancy to see how it affects them and their babies.

More Health Related Quality of Life trials

Quick facts

Study typeObservational
Ages21 Years to 45 Years
SexWomen only
Enrollment150 (estimated)
SponsorPost Graduate Institute of Medical Education and Research, Chandigarh
Academic / other
Locations1 site (Chandigarh, Chandigarh)
StatusRecruiting
StartedDecember 8, 2022
Main results expectedJuly 2026
Study endsJuly 2026
Registry record updatedMay 18, 2026
Trial IDNCT05691036 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women over 21 years old with consistent itching and elevated liver enzymes or bile acids.

Probably not a fit

Patients with viral liver diseases or primary dermatologic conditions causing pruritus will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on Intrahepatic Cholestasis of Pregnancy (ICP), a condition characterized by severe itching and elevated bile acids during pregnancy. It aims to analyze the metabolic profile of bile acids and the genetic mutation profile in affected women from the Indian population. The study will include women over 21 years old who experience consistent pruritus and elevated liver enzymes or bile acids. Participants will be monitored until delivery to assess maternal and perinatal outcomes.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and management of ICP, potentially improving outcomes for mothers and their babies.

How similar studies have gone: While there have been studies on ICP, this specific focus on bile acids and genetic mutations in the Indian population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria -

* Age \> 21 years with consistent pruritus
* Characterized by consistent pruritus associated with elevated levels of serum transaminases (ALT \> 40 U/L or AST \> 37 U/L) or raised total serum bile acids (≥ 10 µmol/L)
* Able to understand and comply with the requirements of the study and voluntarily agrees to participate in the study by giving written informed consent before any study-related activity is performed
* Voluntary informed consent to participate until their delivery and also willing to be followed until their delivery
* Agrees to provide information on perinatal and maternal outcomes at or after delivery

Exclusion Criteria:

* Viral and Infectious diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV) related liver disease, Epstein Barr virus (EBV), Cytomegalovirus (CMV), human immunodeficiency virus (HIV) infection) hepatitis C virus (HBV), hepatitis E virus (HEV)
* Primary dermatologic diseases associated with pruritus
* Metabolic diseases (including alcohol abuse)
* Other causes of cholestasis (i.e., primary biliary cholangitis (PBC); primary sclerosing cholangitis (PSC)
* Autoimmune liver disease
* Obstructive biliary diseases
* Cholestatic drug-induced liver injury
* Clinical severe conditions that may affect outcomes include heart failure, renal failure, primary cardiopulmonary diseases
* Twins and triplet pregnancy

Where it's running

  • Dr. Madhumita Premkumar
    Chandigarh, Chandigarh, India
    Recruiting

Study contacts

  • Principal investigator: Madhumita Premkumar — PGIMER, Chandigarh
  • Study coordinator: Dr Madhumita Premkumar, DM
  • Email: drmadhumitap@gmail.com
  • Phone: 7087003409

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.